[Hepatobiliary complications following allogeneic hematopoietic cell transplantation: Recommendations of the Francophone Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].
Complications hépatobiliaires dans le contexte de l’allogreffe de cellules hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).
Allografts
Biliary Tract Diseases
/ diagnosis
Chemical and Drug Induced Liver Injury
/ diagnosis
Disease Management
Graft vs Host Disease
/ diagnosis
Hematopoietic Stem Cell Transplantation
/ adverse effects
Hepatitis, Viral, Human
/ diagnosis
Humans
Iron Overload
/ diagnosis
Liver Diseases
/ diagnosis
Time Factors
Transplantation Conditioning
/ adverse effects
Allogeneic stem cell transplantation
Allogreffe de cellules souches hématopoïétiques
Complications hépatobiliaires
Hepatobiliary complications
Journal
Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
04
12
2018
revised:
31
01
2019
accepted:
18
02
2019
pubmed:
7
4
2019
medline:
4
3
2020
entrez:
7
4
2019
Statut:
ppublish
Résumé
Hepatobiliary complications are frequent in the context of allogeneic hematopoietic cell transplantation (allo-HCT) and contribute largely to the morbidity and mortality after transplantation. Within the framework of the ninth workshops of practice harmonization of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) held in Lille in September 2018, diagnostic approaches and treatments of hepatobiliary dysfunctions prior to and following transplantation were reviewed according to the analysis of published studies.
Identifiants
pubmed: 30952358
pii: S0007-4551(19)30123-7
doi: 10.1016/j.bulcan.2019.02.005
pii:
doi:
Types de publication
Consensus Development Conference
Journal Article
Practice Guideline
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
S18-S27Informations de copyright
Copyright © 2019 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.